Cognyte Software (NASDAQ:CGNT – Get Free Report) released its quarterly earnings data on Tuesday. The medical device company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.07, Briefing.com reports. The firm had revenue of $84.40 million for the quarter, compared to analysts’ expectations of $83.69 million. Cognyte Software had a negative net margin of 3.70% and a negative return on equity of 5.94%. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.11) earnings per share. Cognyte Software updated its FY 2025 guidance to -0.030–0.030 EPS and its FY25 guidance to $(0.03) EPS.
Cognyte Software Price Performance
Shares of NASDAQ CGNT opened at $6.30 on Thursday. Cognyte Software has a 1 year low of $4.00 and a 1 year high of $8.70. The company’s 50-day moving average is $7.43 and its 200 day moving average is $7.50. The stock has a market capitalization of $447.44 million, a P/E ratio of -37.06 and a beta of 1.74.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the company. Needham & Company LLC restated a “hold” rating on shares of Cognyte Software in a report on Tuesday. Wedbush lifted their price objective on Cognyte Software from $8.00 to $9.00 and gave the stock a “neutral” rating in a research report on Thursday, June 20th. Finally, StockNews.com downgraded Cognyte Software from a “strong-buy” rating to a “buy” rating in a report on Wednesday.
Cognyte Software Company Profile
Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company offers network intelligence analytics, threat intelligence analytics, decision intelligence analytics, and operational intelligence analytics solutions.
Featured Stories
- Five stocks we like better than Cognyte Software
- Dividend Payout Ratio Calculator
- Understanding Treasury Bonds: Are They Right for Your Portfolio?
- With Risk Tolerance, One Size Does Not Fit All
- Morgan Stanley Names Arm Holdings a Top Pick: Here’s Why
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Banking Stocks Slide: Where to Invest Instead
Receive News & Ratings for Cognyte Software Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognyte Software and related companies with MarketBeat.com's FREE daily email newsletter.